Skip to content

Clinical trials

Hepatic Insufficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Insufficiency Country / region: United States Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20062
20071
20083
20093
20102
20111
20137
20142
20153
20173
20182
20195
20201
20222
20232
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Terminated4
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company10
Pfizer5
Merck Sharp & Dohme LLC4
Boehringer Ingelheim3
Bristol-Myers Squibb3
Acerta Pharma BV2
Bausch Health Americas, Inc.2
Allergan1
Axcella Health, Inc1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Insufficiency52
Liver Diseases11
Hepatic Encephalopathy4
Liver Failure4
Brain Diseases3
Fibrosis3
Hepatitis C2
Lymphoma, Follicular2
Neoplasms2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.